Osaic Holdings’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.34K | Buy |
1,915
+196
| +11% | +$445 | ﹤0.01% | 6204 |
|
|
2025
Q1 | $2.16K | Sell |
1,719
-196
| -10% | -$247 | ﹤0.01% | 6439 |
|
|
2024
Q4 | $4.34K | Buy |
1,915
+1,214
| +173% | +$2.75K | ﹤0.01% | 6162 |
|
|
2024
Q3 | $2.42K | Hold |
701
| – | – | ﹤0.01% | 6376 |
|
|
2024
Q2 | $3.58K | Hold |
701
| – | – | ﹤0.01% | 6207 |
|
|
2024
Q1 | $5.89K | Sell |
701
-15
| -2% | -$126 | ﹤0.01% | 5914 |
|
|
2023
Q4 | $2.93K | Sell |
716
-283
| -28% | -$1.16K | ﹤0.01% | 6281 |
|
|
2023
Q3 | $3K | Buy |
999
+283
| +40% | +$849 | ﹤0.01% | 6376 |
|
|
2023
Q2 | $22.1K | Sell |
716
-13
| -2% | -$402 | ﹤0.01% | 5479 |
|
|
2023
Q1 | $36K | Sell |
729
-7
| -1% | -$346 | ﹤0.01% | 5172 |
|
|
2022
Q4 | $16K | Buy |
736
+13
| +2% | +$283 | ﹤0.01% | 5686 |
|
|
2022
Q3 | $48K | Hold |
723
| – | – | ﹤0.01% | 4921 |
|
|
2022
Q2 | $31K | Hold |
723
| – | – | ﹤0.01% | 5299 |
|
|
2022
Q1 | $1.33M | Buy |
723
+48
| +7% | +$88.2K | ﹤0.01% | 2308 |
|
|
2021
Q4 | $40K | Sell |
675
-53
| -7% | -$3.14K | ﹤0.01% | 5285 |
|
|
2021
Q3 | $37K | Hold |
728
| – | – | ﹤0.01% | 5321 |
|
|
2021
Q2 | $42K | Sell |
728
-871
| -54% | -$50.3K | ﹤0.01% | 5162 |
|
|
2021
Q1 | $92K | Buy |
1,599
+148
| +10% | +$8.52K | ﹤0.01% | 4398 |
|
|
2020
Q4 | $99K | Sell |
1,451
-2,289
| -61% | -$156K | ﹤0.01% | 4039 |
|
|
2020
Q3 | $948K | Buy |
3,740
+3,220
| +619% | +$816K | ﹤0.01% | 1880 |
|
|
2020
Q2 | $87K | Sell |
520
-47
| -8% | -$7.86K | ﹤0.01% | 3773 |
|
|
2020
Q1 | $40K | Buy |
+567
| New | +$40K | ﹤0.01% | 4121 |
|